AIIM Trial: Personalized Medicine Approach to Kidney Allograft Function

Phenotypic Personalized Medicine (PPM) will mediate mechanism-independent and patient specific optimization of immunosuppression. We have developed a powerful platform that allows the provider to use clinical data to construct a Parabolic Response Surface (PRS). Using this visualization of the data, the provider can them make a decision on the optimal combination of drug doses needed to achieve the desired outcome.

Providers will decide on the combination of drug doses needed based on their overall assessment per standard of care.